SARS-CoV-2 Receptor-Binding Domain IgG Response to AstraZeneca (AZD1222) COVID-19 Vaccination, Jamaica

The Caribbean region is lacking an assessment of the antibody response and side effects experienced after AstraZeneca COVID-19 vaccination (AZD1222). We examined severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike receptor-binding domain (RBD) IgG levels and report the side effects no...

Descripción completa

Detalles Bibliográficos
Autores principales: Leys, Ynolde E., Nwokocha, Magdalene, Walker, Jerome P., Butterfield, Tiffany R., Frater, Velesha D., Thompson, Tamara K., Anderson, Mark, Cloherty, Gavin A., Anzinger, Joshua J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128703/
https://www.ncbi.nlm.nih.gov/pubmed/35320778
http://dx.doi.org/10.4269/ajtmh.21-1128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128703/
https://www.ncbi.nlm.nih.gov/pubmed/35320778
http://dx.doi.org/10.4269/ajtmh.21-1128

Ejemplares similares